Announcements Trials
Browse Landscape

Phase

Phase 4 4Phase NA 1Phase 3 1Phase 2 1

Status

Unknown 1Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 4Gastrointestinal 3Sarcoma 1Gynecologic 1CNS 1

Conditions

Breast Neoplasms 4Seroma 2Postoperative Hemorrhage 1Hematoma 1Blood Loss, Surgical 1

Interventions

Letrozole 23Docetaxel 17Cyclophosphamide 13Zoledronic Acid 12Trastuzumab 12Anastrozole 12exemestane 11Tamoxifen 11Paclitaxel 11Capecitabine 10Fulvestrant 8Epirubicin 8pegfilgrastim 7Saline Solution 7Bupivacaine 7pertuzumab 6liposomal doxorubicin 6abemaciclib 6Sodium Chloride 6Filgrastim 6Carboplatin 6pegylated granulocyte colony-stimulating factor 5palbociclib 5Ropivacaine 5Dexmedetomidine 5Bevacizumab 5ribociclib 4eribulin 4Vinorelbine 4Tranexamic Acid 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 4 × Tranexamic Acid × Breast × Clear all
NCT05807074 2025-09-29

Impact of Topical Tranexamic Acid in Breast Reconstruction

University of California, San Francisco

Phase 4 Terminated
23 enrolled 9 charts
Breast

Breast Neoplasms

NCT06428682 2024-06-05

Role of TXA in Patients Undergoing Breast Free Flap Reconstruction

University of Virginia

Phase 4 Recruiting
100 enrolled
Breast

Breast Neoplasms, Blood Loss, Surgical

NCT03738527 2021-02-21

SEROMA

Hamilton Health Sciences Corporation

Phase 4 Unknown
100 enrolled
Breast

Breast Neoplasms, Hematoma, Seroma

NCT02627560 2020-05-12

The Effect of Topical Tranexamic Acid on Bleeding and Seroma Formation in After Undergoing Mastectomy

St. Olavs Hospital

Phase 4 Completed
202 enrolled
Breast

Breast Neoplasms, Postoperative Hemorrhage, Seroma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡